May 11, 2008 - Volume 22 - Issue 8
pp: 913-998


Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients

del Valle, José; Mira, José A; de los Santos, Ignacio; More

AIDS . 22(8):923-930, May 11, 2008.

High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets

Nijland, Hanneke MJ; L'homme, Rafaëlla FA; Rongen, Gerard A; More

AIDS . 22(8):931-935, May 11, 2008.


The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients

Sasadeusz, Joe; Audsley, Jennifer; Mijch, Anne; More

AIDS . 22(8):947-955, May 11, 2008.

Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline

Kilby, J Michael; Lee, Ha Youn; Hazelwood, J Darren; More

AIDS . 22(8):957-962, May 11, 2008.